Medical Policies
Medical policies are documents that define the plan coverage for technologies, procedures and treatments. The statements of medical necessity in the policies, about whether a technology, procedure, treatment, supply, equipment, drug or other service improves the health outcome of the population for which said technology or treatment was designed are based on scientific evidence, clinical studies and professional opinions from our providers and recognized medical organizations.
Each document displayed on this website is provided for informational purposes only and is not an authorization, explanation of benefits, or contract. Receiving benefits is subject to satisfaction of all terms and conditions of coverage. Medical technology is constantly changing, and we reserve the right to periodically review and update our policies.
- 1
- 2
ID | Title | Last Review | Next Review | Description | Access |
---|---|---|---|---|---|
M5.001.021 | Biological Treatments for Refractory Myasthenia Gravis | Jun 27, 2024 | Jun 20, 2025 | Eculizumab and ravulizumab-cwvz - initial treatment eculizumab and ravulizumab-cwvz may be... | View |
M5.001.022 | Ultomiris® (ravulizumab-cwvz) | Jun 27, 2024 | Jun 20, 2025 | Coverage is provided in the following conditions: • patient is at least 18 years of age (unless... | View |
- 1
- 2